Gaurav Narula: India’s first CAR-T cell therapy
Gaurav Narula, Professor Paediatric Oncology and Health Sciences at Tata Memorial Center, shared the following post by Droupadi Murmu, President of India on X:
“India’s first CAR-T cell therapy is developed through collaboration between the Indian Institute of Technology, Bombay and Tata Memorial Hospital in association with industry partner ImmunoACT. So, we have two of India’s pioneering research institutes in their respective fields, joining hands with industry for a humanitarian cause.”
Quoting Gaurav Narula post:
“Grateful and inspired by your words Hon’ble Droupadi Murmu, dedicating CART to the nation of India. Proud to meet Supreme Commander. Thankful for our partnership Tata Memorial Hospital, IIT Bombay, ImmunoACT, Rahul Purwar and Hasmukh Jain. Was a long road to get here- my navigator, Yol Bolsun.”
Proceed to video attached to post.
Source: Gaurav Narula/X and Droupadi Murmu/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023